Pharmaceuticals, Drugs, Metabolites |
Montelukast sodium tablets (USP 40th| Dissolution) |
Montelukast |
PH12S05-1003WT |
YMC-Pack Phenyl
|
|
Pharmaceuticals, Drugs, Metabolites |
Montelukast sodium oral granules (USP 40th| Dissolution) |
Montelukast |
PH12S05-1003WT |
YMC-Pack Phenyl
|
|
Pharmaceuticals, Drugs, Metabolites |
Losartan potassium (JP 16th|Assay) |
Losartan potassium |
TA12S05-2504WT |
YMC-Triart C18
|
|
Pharmaceuticals, Drugs, Metabolites |
Antiepileptics |
Ethosuximide Primidone Phenobarbital sodium salt Phenytoin Carbamazepine |
AS12S05-1546WT |
YMC-Pack Pro C18
|
|
Pharmaceuticals, Drugs, Metabolites |
Losartan potassium (JP 16th|Related substances) |
Losartan potassium |
TA12S05-2504WT |
YMC-Triart C18
|
|
Pharmaceuticals, Drugs, Metabolites |
Amlodipine besilate orally disintegrating tablets (JP draft|Assay) |
Amlodipine besilate |
TA12S05-1546WT |
YMC-Triart C18
|
|
Pharmaceuticals, Drugs, Metabolites |
Anti-human immunodeficiency virus (HIV) agents |
DDC DDI D4T AZT |
OC12S05-1546WT |
YMC-Pack C8
|
|
Pharmaceuticals, Drugs, Metabolites |
Nelarabine |
Nelarabine enantiomer Nelarabine |
KSC99S05-2546WT |
CHIRAL ART Cellulose-SC
|
|
Pharmaceuticals, Drugs, Metabolites |
Amlodipine besilate (JP draft|Related substances) |
Amlodipine besilate |
TA12S05-1546WT |
YMC-Triart C18
|
|
Pharmaceuticals, Drugs, Metabolites |
Anti-human immunodeficiency virus (HIV) agents |
DDC DDI D4T AZT |
AA12S05-1546WT |
YMC-Pack ODS-A
|
|
Pharmaceuticals, Drugs, Metabolites |
DL-Phenylethyl amine |
DL-Phenylethyl amine |
KSB99S05-2546WT |
CHIRAL ART Cellulose-SB
|
|
Pharmaceuticals, Drugs, Metabolites |
High sensitivity screening of antineoplastic drugs using a 1 mm ID YMC-Triart C18 UHPLC column |
Gemcitabine Methotrexate Ifosfamide Cyclophosphamide Etoposide Docetaxel |
TA12SP9-0501WT |
YMC-Triart C18
|
|
Pharmaceuticals, Drugs, Metabolites |
Anti-human immunodeficiency virus (HIV) agents |
DDC DDI D4T AZT |
BU12S05-1546WT |
YMC-Pack C4
|
|
Pharmaceuticals, Drugs, Metabolites |
Losartan potassium (USP 34th| Assay) |
Losartan potassium |
TA12S05-2504WT |
YMC-Triart C18
|
|
Pharmaceuticals, Drugs, Metabolites |
Eletriptan hydrobromide |
Eletriptan hydrobromide |
KSB99S05-2546WT |
CHIRAL ART Cellulose-SB
|
|
Pharmaceuticals, Drugs, Metabolites |
8-OHdG, an oxidative stress marker and related compounds in HILIC mode |
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) (-)-Cotinine (-)-Nicotine 7-Methylguanine (m7Gua) 8-Hydroxy-2’-deoxyguanosine (8-OHdG) |
TDH12SP9-10Q1PT |
YMC-Triart Diol-HILIC
|
|
Pharmaceuticals, Drugs, Metabolites |
Losartan potassium and Hydrochlorothiazide tablets (USP 34th| Assay) |
Hydrochlorothiazide Losartan potassium |
TO12S05-1504WT |
YMC-Triart C8
|
|
Pharmaceuticals, Drugs, Metabolites |
Ipriflavone (JP 16th| Assay, Related Substance) |
Ipriflavone |
TO12S05-1504WT |
YMC-Triart C8
|
|
Pharmaceuticals, Drugs, Metabolites |
8-OHdG, an oxidative stress marker and related compounds in RP mode |
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) (-)-Cotinine (-)-Nicotine 7-Methylguanine (m7Gua) 8-Hydroxy-2’-deoxyguanosine (8-OHdG) |
TA12SP9-05Q1PT |
YMC-Triart C18
|
|
Pharmaceuticals, Drugs, Metabolites |
Losartan potassium (USP 34th| Chromatographic purity) |
Losartan potassium Triphenylmethanol |
TA12S05-2504WT |
YMC-Triart C18
|
|